Listed

Opus Genetics, Inc.

IRDNasdaqCIK 1228627HealthcareFiscal year ends Dec 31

Reports and events: 309 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Opus Genetics, Inc., Reports and events
FiledFormWhat it isAccession number
2019-08-2906:45 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001140361-19-015750
2019-08-0707:00 ET10-QQuarterly reportPeriod 2019-06-300001140361-19-014413
2019-08-0706:43 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001140361-19-014411
2019-06-0714:19 ET8-K5.07 Shareholder vote results0001140361-19-010648
2019-05-2912:56 ET8-K3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-19-009949
2019-05-1016:16 ET10-QQuarterly reportPeriod 2019-03-310001140361-19-008945
2019-04-2916:42 ETDEF 14AProxy statementPeriod 2019-06-060001140361-19-007856
2019-04-1608:03 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001140361-19-007130
2019-04-1208:15 ET8-K5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001140361-19-006977
2019-03-2616:13 ET8-K5.07 Shareholder vote results0001567619-19-007648
2019-03-1106:54 ET8-K7.01 Regulation FD disclosure0001140361-19-004634
2019-03-0716:27 ET10-KAnnual reportPeriod 2018-12-310001140361-19-004539
2019-03-0616:23 ET8-K5.02 Departure or appointment of officers or directors0001140361-19-004489
2019-03-0117:10 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-19-004259
2019-02-1416:50 ETDEF 14AProxy statementPeriod 2019-03-260001140361-19-003255
2019-01-2516:51 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001140361-19-001600
2019-01-2216:48 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001140361-19-001362
2018-12-0316:53 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-18-044418
2018-11-1616:45 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-18-043281
2018-11-0216:20 ET10-QQuarterly reportPeriod 2018-09-300001140361-18-042255
2018-10-1909:19 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001140361-18-040906
2018-08-3009:43 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001140361-18-037339
2018-08-2108:07 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-18-036732
2018-08-0316:21 ET10-QQuarterly reportPeriod 2018-06-300001140361-18-035394
2018-07-2315:21 ETDEF 14AProxy statementPeriod 2018-08-300001140361-18-033155
2018-06-2816:03 ET8-K5.07 Shareholder vote results; 8.01 Other events0001140361-18-030409
2018-06-1817:08 ET8-K5.07 Shareholder vote results0001140361-18-028999
2018-05-0416:25 ET10-QQuarterly reportPeriod 2018-03-310001140361-18-021763
2018-04-2316:29 ETDEF 14AProxy statementPeriod 2018-06-140001140361-18-019246
2018-04-1818:01 ET8-K7.01 Regulation FD disclosure0001140361-18-018840
2018-03-0916:16 ET10-KAnnual reportPeriod 2017-12-310001140361-18-012817
2018-02-0816:52 ET8-K1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001140361-18-005827
2018-01-1907:30 ET8-K7.01 Regulation FD disclosure0001140361-18-002482
2018-01-0416:23 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-18-000847
2017-12-2116:15 ET8-K5.08 Item not in the standard list0001140361-17-046996
2017-12-1216:20 ET8-K5.02 Departure or appointment of officers or directors0001140361-17-045883
2017-11-0316:16 ET10-QQuarterly reportPeriod 2017-09-300001140361-17-040967
2017-10-1716:45 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001140361-17-038868
2017-10-1309:21 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001140361-17-038582
2017-09-0109:16 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-17-034064
2017-08-0416:16 ET10-QQuarterly reportPeriod 2017-06-300001140361-17-030254
2017-06-1216:36 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001140361-17-024691
2017-06-0708:58 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001140361-17-024258
2017-05-0516:30 ET8-K5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-17-018620
2017-05-0316:28 ET10-QQuarterly reportPeriod 2017-03-310001140361-17-018125
2017-04-1316:33 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001140361-17-015797
2017-02-2416:25 ETDEF 14AProxy statementPeriod 2017-04-110001140361-17-009142
2017-02-2416:16 ET10-KAnnual reportPeriod 2016-12-310001140361-17-009132
2016-11-2516:03 ET8-K5.08 Item not in the standard list0001140361-16-087883
2016-11-0416:14 ET10-QQuarterly reportPeriod 2016-09-300001140361-16-084902

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 19:22 ET. Listed shows no prices and gives no investment advice.